RTW Royalty I

RTW Royalty I is a specialized investment vehicle managed by RTW Investments, a leading life sciences investment firm based in New York. The entity is designed to acquire royalty interests and milestone payments in pharmaceutical products and medical technologies, providing non-dilutive capital to biotechnology companies. By focusing on royalty-bearing assets, RTW Royalty I participates in the commercial success of de-risked or late-stage therapeutic programs across various medical fields. It represents a key component of RTW's strategy to support innovation through creative financing solutions. Notable interests include royalty agreements with companies such as Rocket Pharmaceuticals and previously Albireo Pharma.